Investigating mechanisms of neuronal nuclear mechanotransduction in physiological conditions and tauopathy
Ended Project Grant Awarded Last action
- Award ID
- F31NS137774
- Recipient
-
The University Of Texas Health Science Center At San Antonio UEI C3KXNLTAAY98
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $111,788
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Place of performance
- San Antonio, TX 78229, USA
Award details come from USAspending.gov.
Description
- Abstract
- Mechanotransduction is the ability of a cell to detect and respond to mechanical stimuli. This tightly regulated process allows cells to adapt to environmental and structural changes. The nucleus is a central regulator of mechanotransduction. As the nucleus detects a change of force, IT responds by altering cell behavior and function. While extensive research in non-neuronal cell types has investigated mechanotransduction in the context of cell proliferation, metastasis, and differentiation within physiological and pathological conditions, few studies have investigated the role of mechanotransduction in neurons. The brain is exposed to changes in mechanical force from the vasculature, direct force impacts with the skull, and neurodegeneration. Tauopathies, including alzheimer's disease, are neurodegenerative disorders that involve the progressive deposition of TAU protein in the brain. Mechanistically, pathogenic forms of TAU have been found to drive neurodegeneration by inducing over-stabilization of the actin cytoskeleton, which causes destabilization of the lamin nucleoskeleton. Nucleoskeletal destabilization drives heterochromatin decondensation, aberrant gene expression, and ultimately neuronal death. I recently reported that neurons harboring pathological TAU have a decrease in nuclear tension and a disruption in the linker of nucleoskeleton to cytoskeleton (linc) complex, an established nuclear mechanosensor. My preliminary studies indicate that neurons harboring pathological TAU have a significant increase of emerin, a mechanosensitive protein that resides on the inner nuclear membrane and binds to a-type lamins. Studies in non-neuronal cells suggest that mechanical stimulation causes emerin to become phosphorylated and translocate to the cytoplasm, where IT regulates actin dynamics. As neurons predominantly express b-type lamins, IT is currently unknown if and how emerin regulates nuclear mechanotransduction in neurons. The overall goal of this proposal is to better understand mechanisms underlying nuclear mechanotransduction in neurons in physiological and pathological conditions. I will test the hypotheses that emerin is mechanosensitive in neurons and interacts directly with b-type lamins, and that pathogenic forms of TAU disrupt nuclear mechanotransduction. Understanding how neurons detect and respond to mechanical forces will be instrumental to our understanding of basic neurobiology and disease.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$4,798 | |
| Amendment | $39,238 | |
| Amendment | $38,674 | |
| Amendment | $0 | |
| Original award | $38,674 |
Quick answers
Who received award F31NS137774?
F31NS137774 was awarded to The University Of Texas Health Science Center At San Antonio by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on January 8, 2025.
How much is award F31NS137774 worth?
$111,788 has been obligated on F31NS137774.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award